Resapp Health Ltd
ASX:RAP
EV/GP
Enterprise Value to Gross Profit
Market Cap | EV/GP | ||||
---|---|---|---|---|---|
AU |
Resapp Health Ltd
ASX:RAP
|
176.2m AUD | 0 | ||
US |
Veeva Systems Inc
NYSE:VEEV
|
32.4B USD | 16.8 | ||
US |
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 6 | ||
US |
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 6.4 | ||
JP |
M3 Inc
TSE:2413
|
1.3T JPY | 8 | ||
AU |
Pro Medicus Ltd
ASX:PME
|
11.4B AUD | 77.5 | ||
US |
Inspire Medical Systems Inc
NYSE:INSP
|
7B USD | 12.4 | ||
US |
Doximity Inc
NYSE:DOCS
|
4.4B USD | 8.9 | ||
SE |
Sectra AB
STO:SECT B
|
42.7B SEK | 52.7 | ||
US |
Evolent Health Inc
NYSE:EVH
|
3.1B USD | 7.7 | ||
US |
Goodrx Holdings Inc
NASDAQ:GDRX
|
2.8B USD | 4.1 |
EV/GP Forward Multiples
Forward EV/GP multiple is a version of the EV/GP ratio that uses forecasted gross profit for the EV/GP calculation. 1-Year, 2-Years, and 3-Years forwards use gross profit forecasts for 1, 2, and 3 years ahead, respectively.